The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DCE-MRI Evaluation of 10 patients with brain metastases treated with RRx-001, a Myc inhibitor and a CD47 and PD-L1 downregulator, in a phase I/II trial called BRAINSTORM.
 
Michelle Miran Kim
Research Funding - EpicentRx (Inst)
 
Hemant Parmar
No Relationships to Disclose
 
Madhava P Aryal
No Relationships to Disclose
 
Scott Caroen
Employment - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - Scott Caroen is on patents relating to EpicentRx, Inc., technologies.
 
Theresa Devasia
No Relationships to Disclose
 
Matthew J Schipper
No Relationships to Disclose
 
Aki Morikawa
Consulting or Advisory Role - Eisai
Research Funding - Eisai (Inst); Eisai (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Merrimack (Inst); Millenium Pharamceuticals (Inst); Novartis (Inst)
 
Daniel Eidelberg Spratt
Consulting or Advisory Role - AstraZeneca; Blue Earth Diagnostics; Janssen Oncology
 
James Hayman
No Relationships to Disclose
 
Larry Junck
No Relationships to Disclose
 
Theodore Steven Lawrence
No Relationships to Disclose
 
Christopher D. Lao
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore
Research Funding - Bristol-Myers Squibb; Dynavax Technologies; Genentech; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Immunocore
 
Yue Cao
No Relationships to Disclose